Further study will now be necessary to understand the precise role of ERO1α within the tumor microenvironment, determine how this enzyme influences ECM remodelling, and assess potential associations with tumor progression via conditional knockout/overexpression in xenograft and genetically engineered mouse models. This evidence concerns the gene ERO1A and neoplasm.